John Greene

1.4k citations

38 papers · 1.0k indexed · 1 hit paper · h-index 11

Impact in

Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing

Papers in ⓘ

Oncology 14
- Cancer Immunotherapy and Biomarkers 4
- Cancer Treatment and Pharmacology 2
Pulmonary and Respiratory Medicine 12
- Prostate Cancer Treatment and Research 5

Co-authors: Anne‐Marie Baird (8 shared papers)Stephen P. Finn (9 shared papers)Marvin Lim (6 shared papers)Ray McDermott (8 shared papers)Steven G. Gray (5 shared papers)Lauren Brady (4 shared papers)Ashvina Segaran (1 shared paper)Simon Lord (1 shared paper)
Journals: Journal of Clinical Oncology (4 papers)Open Forum Infectious Diseases (3 papers)Scientific Reports (2 papers)Cancers (2 papers)Journal of Thoracic Oncology (1 paper)
Partner nations: Ireland United States United Kingdom

In The Last Decade

John Greene

29 papers receiving 991 citations

Hit Papers

align trajectories log scale

Circular RNAs: Biogenesis, Function and Role in Human Diseases 2017 · 442 citations

Peers

Countries citing papers authored by John Greene

Since Specialization

Citations

This map shows the geographic impact of John Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Greene more than expected).

Fields of papers citing papers by John Greene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Greene. The network helps show where John Greene may publish in the future.

Co-authors

The 25 scholars most cited alongside John Greene, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Greene Line = papers co-authored together John Greene links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Circular RNAs: Biogenesis, Function and Role in Human Diseases Frontiers in Molecular Biosciences ·John Greene, Anne‐Marie Baird, Lauren Brady, Marvin Lim, Steven G. Gray, Ray McDermott, Stephen P. Finn Hit paper breakdown →	2017	442
2	Initiating oncogenic event determines gene-expression patterns of human breast cancer models Proceedings of the National Academy of Sciences ·Kartiki V. Desai, Nianqing Xiao, Weili Wang, Lisa Gangi, John Greene, John Powell, Robert B. Dickson, Priscilla A. Furth, Kent W. Hunter, Raju Kucherlapati, Richard H. Simon, Edison T. Liu, Jeffrey E. Green	2002	152
3	Targeting OXPHOS and the electron transport chain in cancer; Molecular and therapeutic implications Seminars in Cancer Biology ·John Greene, Ashvina Segaran, Simon Lord	2022	133
4	Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide Scientific Reports ·John Greene, Anne‐Marie Baird, Órla Casey, Lauren Brady, Gordon Blackshields, Marvin Lim, Odharnaith O’Brien, Steven G. Gray, Ray McDermott, Stephen P. Finn	2019	74
5	Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro‐tumourigenic ‘activated’ state that enhances prostate cancer cell migration International Journal of Cancer ·Sarah Ridge, Dibyangana D. Bhattacharyya, Eoin Dervan, Serika D. Naicker, Amy Burke, Mary Murphy, Karen O’Leary, John Greene, Aideen E. Ryan, Francis Sullivan, Sharon A. Glynn	2017	30
6	Effectiveness of Reminder Systems on Appointment Adherence Rates Journal of Health Care for the Poor and Underserved ·Susan Maxwell, Rose Maljanian, Sheryl Horowitz, Mary Ann Pianka, Yolanda Cabrera, John Greene	2001	26
7	The role of anthracyclines in the treatment of early breast cancer Journal of Oncology Pharmacy Practice ·John Greene, Bryan T. Hennessy	2014	24
8	RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer—From Cell Line Models to Liquid Biopsies Diagnostics ·Marvin Lim, Anne‐Marie Baird, John Aird, John Greene, D.N. Kapoor, Steven G. Gray, Ray McDermott, Stephen P. Finn	2018	19
9	Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines Cancers ·Noel E. Donlon, Andrew Sheppard, Maria Davern, Fiona O’Connell, J.J. Phelan, Robert Power, Timothy Nugent, Kate Dinneen, John Aird, John Greene, Paul Nevins Selvadurai, Anshul Bhardwaj, Emma K. Foley, Narayanasamy Ravi, Claire L. Donohoe, John V. Reynolds, Joanne Lysaght, Jacintha O’Sullivan, Margaret R. Dunne	2020	15
10	Differential CircRNA Expression Signatures May Serve as Potential Novel Biomarkers in Prostate Cancer Frontiers in Cell and Developmental Biology ·John Greene, Anne‐Marie Baird, Marvin Lim, Joshua Flynn, Ciara S. McNevin, Lauren Brady, Orla Sheils, Steven G. Gray, Ray McDermott, Stephen P. Finn	2021	15
11	Toxicity and Efficacy of Benzamide Riboside in Cancer Chemotherapy Models Current Medicinal Chemistry ·Hiremagalur N. Jayaram, Joel A. Yalowitz, Francisco Arguello, John Greene	2002	12
12	Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness Scientific Reports ·Louise Flynn, Martin P. Barr, Anne‐Marie Baird, Paul Smyth, Órla Casey, Gordon Blackshields, John Greene, Stephen R. Pennington, Emily Hams, Padraic G. Fallon, John O’Leary, Orla Sheils, Stephen P. Finn	2020	10
13	hsa_circ_0001275 Is One of a Number of circRNAs Dysregulated in Enzalutamide Resistant Prostate Cancer and Confers Enzalutamide Resistance In Vitro Cancers ·Marvin Lim, Anne‐Marie Baird, John Greene, Ciara S. McNevin, Karine Ronan, Petar Podlesniy, Orla Sheils, Steven G. Gray, Ray McDermott, Stephen P. Finn	2021	8
14	Radium-223 in combination with enzalutamide in metastatic castration-resistant prostate cancer: a multi-centre, phase II open-label study Therapeutic Advances in Medical Oncology ·Ray McDermott, John Greene, John McCaffrey, Imelda Parker, Sylva Helanova, Anne‐Marie Baird, Ausra Teiserskiene, Marvin Lim, Helen Matthews, Olwyn Deignan, John Feeney, P. Thirion, Stephen P. Finn, Paul J. Kelly	2021	8
15	Dirofilaria tenuis Causing Neuritis Infectious Diseases in Clinical Practice ·Alexander D. Vincent, John Greene, Veronica Tucci, Margarita R. Cabrera-Cancio	2013	5
16	The prognostic value of the derived neutrophil-to-lymphocyte ratio (dNLR) in patients treated with immune checkpoint inhibitors Irish Journal of Medical Science (1971 -) ·William Mullally, John Greene, Emmet Jordan, Anne M. Horgan, Miriam O’Connor, Paula Calvert	2022	4
17	Real world experience with pembrolizumab and nivolumab for treatment of non-small cell lung cancer (NSCLC) in an Irish Regional Cancer Center. Journal of Clinical Oncology ·Colum Dennehy, Will Mullally, Caitríona Goggin, Jack P. Gleeson, John Greene, Derek Gerard Power, Séamus O’Reilly, Dearbhaile Catherine Collins, Deirdre O’Mahony, Richard Bambury	2018	4
18	Bronchoesophageal Fistula in a Patient With Stage IIIB Non–Small-Cell Lung Cancer Journal of Thoracic Oncology ·Grzegorz Korpanty, Scheryll Alken, Lillian Smyth, John Greene, Aya El Helali, Liam Grogan, Oscar S. Breathnach	2012	3
19	Streptomyces Pneumonia in an Immunocompromised Patient Infectious Diseases in Clinical Practice ·Abraham Tareq Yacoub, Ana Paula Velez, Sara I. Khwaja, Ramón L. Sandin, John Greene	2014	3
20	Respiratory infections in patients with cancer John C. Ruckdeschel, John Greene, K. Eric Sommers, Karen K. Fields	2003	3

About John Greene

John Greene is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Infectious Diseases, having authored 38 papers that have together received 1.0k indexed citations. Recurring topics across this work include Circular RNAs in diseases (5 papers), Prostate Cancer Treatment and Research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Fungal Infections and Studies (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Cancer Research (588 citations), Molecular Biology (754 citations), Oncology (160 citations), Pulmonary and Respiratory Medicine (102 citations) and Immunology (58 citations). John Greene has collaborated with scholars based in Ireland, United States and United Kingdom. Frequent co-authors include Anne‐Marie Baird, Stephen P. Finn, Marvin Lim, Ray McDermott, Steven G. Gray, Lauren Brady, Ashvina Segaran, Simon Lord, John Powell and Richard H. Simon. Their work appears in journals such as Journal of Clinical Oncology, Open Forum Infectious Diseases, Scientific Reports, Cancers and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact